2 research outputs found

    Completely N<sup>1</sup>-Selective Palladium-Catalyzed Arylation of Unsymmetric Imidazoles: Application to the Synthesis of Nilotinib

    No full text
    The completely N<sup>1</sup>-selective Pd-catalyzed arylation of unsymmetric imidazoles with aryl halides and triflates is described. This study showed that imidazoles have a strong inhibitory effect on the in situ formation of the catalytically active Pd(0)–ligand complex. The efficacy of the N-arylation reaction was improved drastically by the use of a preactivated solution of Pd<sub>2</sub>(dba)<sub>3</sub> and <b>L1</b>. From these findings, it is clear that while imidazoles can prevent binding of <b>L1</b> to Pd, once the ligand is bound to the metal, these heterocycles do not displace it. The utility of the present catalytic system was demonstrated by the regioselective synthesis of the clinically important tyrosine kinase inhibitor nilotinib

    Me<sub>3</sub>(OMe)<i>t</i>BuXPhos: A Surrogate Ligand for Me<sub>4</sub><i>t</i>BuXPhos in Palladium-Catalyzed C–N and C–O Bond-Forming Reactions

    No full text
    A new biarylphosphine ligand, Me<sub>3</sub>(OMe)<i>t</i>BuXPhos (<b>L3</b>), was designed as a surrogate for Me<sub>4</sub><i>t</i>BuXPhos (<b>L1</b>). The Me<sub>3</sub>(OMe)<i>t</i>BuXPhos could be prepared in a chromatography-free manner from inexpensive and readily available 2,3,6-trimethylphenol. Comparative studies demonstrated that a catalyst based on Me<sub>3</sub>(OMe)<i>t</i>BuXPhos displayed the same reactivity as a catalyst based on Me<sub>4</sub><i>t</i>BuXPhos for Pd-catalyzed C–N and C–O bond-forming processes